[et_pb_section fb_built=”1″ _builder_version=”3.22″ custom_padding=”54px|0px|0|0px|false|false”][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_padding=”27px|0px|0|0px|false|false”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.4.4″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″]

Volume XVI (2009-2010)

Issue 2: Fall 2009

Introduction: contains Cover, Table of Contents, Letter from the Editor, and Masthead


4.   The Regulation of Nanomedicine: Will the Exisiting Regulatory Scheme of the FDA Suffice? — Shanna Harris

5.   Will the Federal Circuit’s Eli Lilly v. Teva Decision Lead to Efforts To Abuse the Modification Provision of the Hatch-Waxman Act? — Claire K. Comfort

6.   Dreadful Policing: Are the Semiconductor Industry Giants Content with Yesterday’s International Protection for Integrated Circuits? — Michael Fuerch

7.   Students’ Free Speech Rights Shed at the Cyber Gate — Vivian Lei

[/et_pb_text][et_pb_divider _builder_version=”3.11″][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section]